Neurotrope
Newark, US · Founded 2013 · Nevada corporation · 1 known investors
Find your way into Neurotrope
Sign up to see every warm intro you have to Neurotrope
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurotrope team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
LD
Larry D. Altstiel, MDBoard director
WS
William SingerVice Chairman of the Board
PE
Paul E. FreimanChairman of the Board
JM
Jay M. HaftBoard director
JG
James GottliebBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$39.8M disclosed across 2 rounds · 2015–2016
▶$24.5MraisedDec 2016 · 221 investors · BiotechnologyRule 506(b)
▶$24.5MraisedDec 2016 · 221 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua SilvermanDirector
- Robert WeinsteinExecutive Officer
- James GottliebDirector
- Shana PharesDirector
- Kenneth GorelickDirector
- Dan AlkonExecutive Officer
- William SingerDirector
- Bruce BernsteinDirector
- Susanne WilkeExecutive Officer, Director
- Offering amount
- $24.5M
- Amount sold
- $24.5M
- Sales commissions
- $2.5M
- Placement agents
- Katalyst Securities LLC, GP Nurmenkari Inc.
- First sale
- Nov 2016
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
▶$15.3MraisedNov 2015 · 136 investors · BiotechnologyRule 506(b)
▶$15.3MraisedNov 2015 · 136 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert WeinsteinExecutive Officer
- Larry D. Altstiel, MDDirector
- William SingerDirector
- Charles S. RamatExecutive Officer, Director
- Paul E. FreimanDirector
- Jay M. HaftDirector
- James GottliebDirector
- Offering amount
- $20M
- Amount sold
- $15.3M
- Sales commissions
- $1.5M
- Placement agents
- Katalyst Securities LLC
- First sale
- Nov 2015
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Neurotrope's investors?
- Neurotrope's investors include NGN Capital.
- How much funding has Neurotrope raised?
- Neurotrope has disclosed $39.8M raised across 2 rounds.
- Where is Neurotrope headquartered?
- Neurotrope is headquartered in Newark, US.